6C47.62

ICD-11 MMS 2026-01

Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms

Description

Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms is characterised by the presence of multiple psychotic symptoms, primarily hallucinations and delusions, when these are judged to be the direct consequence of synthetic cathinone use. The symptoms do not occur exclusively during hypnogogic or hypnopompic states, are not better accounted for by another mental and behavioural disorder (e.g., Schizophrenia), and are not due to another disorder or disease classified elsewhere (e.g., epilepsies with visual symptoms).

Index terms

  • Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms
  • Synthetic cathinone-induced psychotic disorder with mixed psychotic features

Exclusions from above levels

  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C47.60 – Synthetic cathinone-induced psychotic disorder with hallucinations
  • 6C47.61 – Synthetic cathinone-induced psychotic disorder with delusions
  • 6C47.6Z – Synthetic cathinone-induced psychotic disorder, unspecified

Foundation entity

Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms – http://id.who.int/icd/entity/89854667

Allowed postcoordination axes

Part of: 6C47.6: Synthetic cathinone-induced psychotic disorder › 6C47: Disorders due to use of synthetic cathinones › 06: Mental, behavioural or neurodevelopmental disorders